慢性呼吸道疾病患者的认知干预:系统审查议定书
Danielle Ryzer1, Bushra Bhatti1, Alana Streicher1
1School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
JMIR research protocols
|July 28, 2023
概括
本系统性审查审查了慢性呼吸道疾病 (CRD) 的认知干预措施. 它旨在总结对认知功能和其他结果的影响,以指导临床实践和未来的研究.
科学领域:
- 神经学 神经学
- 肺部病理学 肺部病理学
- 认知科学 认知科学
背景情况:
- 慢性呼吸道疾病 (CRD) 可以导致氧气供应减少,增加缺血损伤风险和随后的脑损伤.
- 这种脑损伤可能表现为神经症状和认知能力下降.
- 认知干预显示出缓解CRD患者认知缺陷的潜力,但证据需要系统合成.
研究的目的:
- 系统地审查认知干预对CRD患者认知功能的影响.
- 评估对与健康有关的生活质量,自我管理,症状,身体功能和日常活动的影响.
- 评估对医院入院,功能能力,心理结果和生存的影响.
主要方法:
- 按照柯克伦手册和PRISMA指南进行系统审查.
- 在多个数据库 (MEDLINE,Embase,PsycINFO等) 中进行搜索. 进行相关研究.
- 使用既有工具进行偏差风险评估;如果数据允许,进行元分析;证据质量等级.
主要成果:
- 系统性审查启动于2022年11月,已注册在PROSPERO (CRD42023396234) 上.
- 计划于2023年6月进行全文选;数据提取和手稿起草2023年7月至8月.
- 预计将于2024年2月公布.
结论:
- 这一审查将巩固关于CRDs认知干预的证据.
- 研究结果将帮助医疗保健专业人员选择有效的认知策略.
- 该研究将确定研究缺口,以指导CRD认知健康的未来调查.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244


